What is the treatment for chillblains?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chilblains (Pernio)

For idiopathic chilblains, cold avoidance and protective measures are first-line management, with oral nifedipine (typically 20 mg three times daily) as the most evidence-based pharmacologic option for severe or refractory cases, though its effectiveness remains inconsistent across studies. 1, 2

Initial Management: Non-Pharmacologic Measures

Cold protection is the cornerstone of treatment and prevention:

  • Avoid cold exposure and keep extremities warm with appropriate clothing (gloves, warm socks, insulated footwear) 1, 3
  • Gradual rewarming is essential—never rewarm extremities suddenly after cold exposure, as rapid warming causes vasospasm and worsens the condition 4
  • Smoking cessation is strongly recommended, as smoking exacerbates vasospasm 1
  • Clean and dry the affected limb thoroughly 3

Common pitfall: Patients often try to rapidly warm cold extremities (e.g., placing hands directly on a heater), which paradoxically worsens symptoms through vasospasm. Emphasize gradual, gentle rewarming. 4

Pharmacologic Treatment Options

First-Line: Calcium Channel Blockers

Nifedipine is the most studied and recommended pharmacologic treatment:

  • Nifedipine produces vasodilation and has been demonstrated to reduce pain, facilitate healing, and prevent new lesions 3
  • A systematic review found moderate evidence supporting nifedipine for severe or refractory idiopathic chilblains 2
  • However, effectiveness is not confirmed by all studies—the evidence remains mixed 1
  • Typical dosing: 20 mg three times daily (though specific dosing should follow standard nifedipine protocols)

Important caveat: While nifedipine is the most evaluated treatment, its inconsistent efficacy across studies means some patients may not respond. 1, 2

Second-Line Options

Pentoxifylline has moderate evidence for severe or refractory cases 2, though fewer studies support its use compared to nifedipine 1

Topical corticosteroids (particularly betamethasone) are commonly used in clinical practice, but their effectiveness has not been confirmed by randomized clinical trials 1

Limited Evidence Treatments

The following have shown benefit only in small numbers of patients:

  • Topical nitroglycerin 1
  • Hydrochloroquine 1
  • Diltiazem 2
  • Vitamin D 2

Acupuncture appears to provide some benefit based on limited data 1

Clinical Evaluation

Screen for secondary causes before diagnosing idiopathic chilblains:

  • Check for systemic symptoms and underlying autoimmune disease 1
  • Laboratory evaluation should include antinuclear antibody profile to exclude systemic lupus erythematosus 3
  • Screen for cryoproteins and antiphospholipid antibodies in appropriate clinical contexts 3
  • Consider anorexia nervosa in thin adolescents, as low BMI (<25th percentile) is a risk factor 3, 5

Skin biopsy can be useful in dubious cases, showing dermal edema and inflammatory infiltrate particularly around eccrine glands 1

Natural History and Prognosis

  • Acute pernio typically develops 12-24 hours after cold exposure 3
  • Lesions usually begin in fall/winter and spontaneously resolve in spring or early summer 1, 3
  • Most patients improve with warmer weather or cold protection advice alone 5
  • The prognosis for properly treated pernio is excellent 3

Reassurance is important: Chilblains are almost always benign, patients are systemically well, and most need only symptomatic treatment. Prompt recognition avoids excessive investigation and anxiety. 5

Treatment Algorithm

  1. All patients: Cold avoidance, protective clothing, gradual rewarming, smoking cessation
  2. Mild cases: Observation with non-pharmacologic measures; consider topical corticosteroids (though unproven)
  3. Moderate-to-severe or refractory cases: Add oral nifedipine
  4. Non-responders to nifedipine: Consider pentoxifylline as alternative
  5. Persistent cases: Re-evaluate for secondary causes; consider referral to rheumatology or dermatology

Special consideration for adolescents: Thin body habitus increases risk—counsel on adequate clothing and avoiding fashion choices that expose extremities to cold (e.g., wearing sandals in winter). 3, 5

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.